Blue Trust Inc’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Blue Trust Inc’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-304	Closed	-$19.7K	–	2831
2024 Q3	$19.7K	Buy	304 +279	+1,116%	+$19.3K	﹤0.01%	1949
2024 Q2	$1.62K	Hold	25	–	–	﹤0.01%	2474
2024 Q1	$1.62K	Buy	+25	New	+$1.63K	﹤0.01%	1860

Other funds holding PBE

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Blue Trust Inc's PBE Position: Q4 2024 in Review

Blue Trust Inc sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2024, closing a stake of 304 shares — an estimated $19.7K sold.

Blue Trust Inc first reported a position in PBE in Q1 2024 and held it in 3 quarters. The position peaked at $19.7K in Q3 2024. 96 funds tracked by Wall St. Rank hold PBE as of Q4 2024.

Blue Trust Inc reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2024 after selling out during the quarter.
Blue Trust Inc sold 304 Invesco Biotechnology & Genome ETF shares in Q4 2024, an estimated $19.7K.
Blue Trust Inc first reported a position in Invesco Biotechnology & Genome ETF in Q1 2024 and held it in 3 quarters.
Blue Trust Inc's Invesco Biotechnology & Genome ETF position peaked at $19.7K in Q3 2024.
96 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.